Sheila Ranganath,Ashok Bhandari,Nicole Avitahl-Curtis,Jaimee McMahon,Derek Wachtel,Jenny Zhang,Christopher Leitheiser,Sylvie G Bernier,Guang Liu,Tran T Tran,Herodion Celino,Jenny Tobin,Joon Jung,Hong Zhao,Katie E Glen,Chris Graul,Aliesha Griffin,Wayne C Schairer,Carolyn Higgins,Tammi L Reza,Eva Mowe,Sam Rivers,Sonya Scott,Alex Monreal,Courtney Shea,Greg Bourne,Casey Coons,Adaline Smith,Kim Tang,Ramya A Mandyam,Jaime Masferrer,David Liu,Dinesh V Patel,Angelika Fretzen,Craig A Murphy,G Todd Milne,Mark L Smythe,Kenneth E Carlson

Abstract:Interleukin-6 (IL-6) is an important member of the cytokine superfamily, exerting pleiotropic actions on many physiological processes. Over-production of IL-6 is a hallmark of immune-mediated inflammatory diseases such as Castleman's Disease (CD) and rheumatoid arthritis (RA). Antagonism of the interleukin IL-6/IL-6 receptor (IL-6R)/gp130 signaling complex continues to show promise as a therapeutic target. Monoclonal antibodies (mAbs) directed against components of this complex have been approved as therapeutics for both CD and RA. To potentially provide an additional modality to antagonize IL-6 induced pathophysiology, a peptide-based antagonist approach was undertaken. Using a combination of molecular design, phage-display, and medicinal chemistry, disulfide-rich peptides (DRPs) directed against IL-6 were developed with low nanomolar potency in inhibiting IL-6-induced pSTAT3 in U937 monocytic cells. Targeted PEGylation of IL-6 binding peptides resulted in molecules that retained their potency against IL-6 and had a prolongation of their pharmacokinetic (PK) profiles in rodents and monkeys. One such peptide, PN-2921, contained a 40 kDa polyethylene glycol (PEG) moiety and inhibited IL-6-induced pSTAT3 in U937 cells with sub-nM potency and possessed 23, 36, and 59 h PK half-life values in mice, rats, and cynomolgus monkeys, respectively. Parenteral administration of PN-2921 to mice and cynomolgus monkeys potently inhibited IL-6-induced biomarker responses, with significant reductions in the acute inflammatory phase proteins, serum amyloid A (SAA) and C-reactive protein (CRP). This potent, PEGylated IL-6 binding peptide offers a new approach to antagonize IL-6-induced signaling and associated pathophysiology.

Selection of Antigenic Determinants Recognized by Neutralizing Monoclonal Antibody Against IL-6 from a Phage Peptide Library

Searching Interleukin 6 Antagonists by Screening Random Peptide Libraries

Screening and Identification of A Targeting Peptide to Nglp-1r from Phage Display Peptide Library

Specific Ligands for Classical Swine Fever Virus Screened from Landscape Phage Display Library.

Identification of Epitope of TNF Recognized by Monoclonal Antibody with Phage-displayed Random Peptide Library.

The design of antagonist peptide of hIL-6 based on the binding epitope of hIL-6 by computer-aided molecular modeling.

Function and molecular modeling of the interaction between human interleukin 6 and its HNK-1 oligosaccharide ligands

Discovery and Characterization of a Potent Interleukin-6 Binding Peptide with Neutralizing Activity In Vivo

Advances in Structural Base of Interaction Between Hil-6 and Its Receptor and Antagonist of Hil-6

The study of SLE associated peptide by phage-display random 15 amino acid peptide library

Screening and identification of CD13-binding peptides with phage display peptide library]

Selection of Human Stem Cell Factor Mimetic Peptides from Phage-Displayed Random Peptide Library

Fine-epitope Mapping of an Antibody That Binds the Ectodomain of Influenza Matrix Protein 2

Identification of host cell binding peptide from an overlapping peptide library for inhibition of classical swine fever virus infection

Unveiling novel insights into human IL-6 - IL-6R interaction sites through 3D computer-guided docking and systematic site mutagenesis

Development of a synthetic library of humanized nanobodies for targeted IL-6 inhibition

Identification of a universal antigen epitope of influenza A virus using peptide microarray

Structure‐function analysis of human IL‐6 receptor: dissociation of amino acid residues required for IL‐6‐binding and for IL‐6 signal transduction through gp130.

[Mimic Epitope Recognized by Monoclonal Antibody MG7 Against Gastric Cancer Through Screening Phage Displayed Random Peptide Library].

Selection of the Minotope of NMDAR1 from Phage Displayed Random Peptide Library

Structure‐Function analysis of human IL‐6: Identification of two distinct regions that are important for receptor binding